ARAV - Aravive Inc
IEX Last Trade
0.228
-0.020 -8.947%
Share volume: 6,895,081
Last Updated: Tue 08 Aug 2023 09:59:54 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$0.25
-0.02
-8.21%
Summary score
22%
Profitability
25%
Dept financing
23%
Liquidity
33%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
42.33%
Return on assets
-23.85%
Return on sales
-1002.65%
Return on invested capital
-35.69%
Total debt ratio
56.58%
Debt ratio change over timeo
-0.94%
Current Ratio
6.03%
Quick Ratio
4.37%
Cash Position Ratio
5.77%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
253.27%
Return on assets
-47.7%
Return on sales
-965.1%
Return on invested capital
-9.47%
Total debt ratio
134.13%
Debt ratio change over timeo
-1.31%
Current Ratio
1.77%
Quick Ratio
1.77%
Cash Position Ratio
1.59%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
1247.85%
Return on assets
-68.31%
Return on sales
-323.44%
Return on invested capital
-337.46%
Total debt ratio
86.96%
Debt ratio change over time
-1.26%
Current Ratio
0.98%
Quick Ratio
0.98%
Cash Position Ratio
0.87%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-146.44%
Return on assets
-105%
Return on sales
-718.8%
Return on invested capital
-76.23%
Total debt ratio
-94.42%
Debt ratio change over time
-0.94%
Current Ratio
-1.53%
Quick Ratio
2.15%
Cash Position Ratio
-1.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ARAV | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 42.33% | 0% | 0% | -117.6% |
| Return on assets | -23.85% | 0% | 0% | -11.99% |
| Return on sales | -1002.65% | 0% | 0% | -8680.79% |
| Return on invested capital | -35.69% | 0% | 0% | -48.11% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 56.58% | 0% | 0% | 77.42% |
| Debt ratio change over time | -0.94% | 0% | 0% | -0.81% |
| Dept financing | 18% | 0% | 25% | 25% |
| Current Ratio | 1.77% | 0% | 0% | 5.35% |
| Quick Ratio | 1.77% | 0% | 0% | 5.34% |
| Cash Position Ratio | 1.59% | 0% | 0% | 5.03% |
| Liquididy | 52% | 0% | 0% | 75% |
| Short-term ratios | ARAV | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 253.27% | 0% | 0% | 146.7% |
| Return on assets | -47.7% | 0% | 0% | -18.66% |
| Return on sales | -965.1% | 0% | 0% | -28500.29% |
| Return on invested capital | -9.47% | 0% | 0% | -371.75% |
| Profitability | 25% | 0% | 75% | 14% |
| Total debt ratio | 134.13% | 0% | 0% | 108.07% |
| Debt ratio change over time | -1.31% | 0% | 0% | -1.53% |
| Dept financing | 25% | 0% | 25% | 20% |
| Current Ratio | 1.77% | 0% | 0% | 5.35% |
| Quick Ratio | 1.77% | 0% | 0% | 5.34% |
| Cash Position Ratio | 1.59% | 0% | 0% | 5.03% |
| Liquididy | 24% | 0% | 0% | 75% |